Literature DB >> 17596578

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

William J M Hrushesky, Michael Retsky, Michael Baum, Romano Demicheli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596578     DOI: 10.1093/jnci/djm019

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Development of a bioassay to monitor circulating plasma Ki-67.

Authors:  Gary Hardiman
Journal:  Leuk Res       Date:  2010-02-20       Impact factor: 3.156

2.  Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Authors:  Jean-Marie Bruey; Hagop Kantarjian; Wanlong Ma; Zeev Estrov; Chenhsiung Yeh; Amber Donahue; Heather Sanders; Susan O'Brien; Michael Keating; Maher Albitar
Journal:  Leuk Res       Date:  2010-04-01       Impact factor: 3.156

3.  Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.

Authors:  Jean-Marie Bruey; Hagop Kantarjian; Zeev Estrov; Zhong Zhang; Wanlong Ma; Ferras Albitar; Adam Abdool; Deborah Thomas; Chenhsiung Yeh; Susan O'Brien; Maher Albitar
Journal:  Leuk Res       Date:  2009-08-12       Impact factor: 3.156

4.  Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.

Authors:  Jihai Jin; Dongxing Zheng; Yujuan Liu
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

5.  A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.

Authors:  Sirwan M Hadad; Lee B Jordan; Pankaj G Roy; Colin A Purdie; Takayuki Iwamoto; Lajos Pusztai; Stacy L Moulder-Thompson; Alastair M Thompson
Journal:  BMC Cancer       Date:  2016-09-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.